Patients with penile cancer and the risk of (pre)malignant cervical lesions in female partners: a retrospective cohort analysis
Article first published online: 26 JUL 2013
© 2013 The Authors. BJU International © 2013 BJU International
Volume 112, Issue 7, pages 905–908, November 2013
How to Cite
de Bruijn, R. E., Heideman, D. A.M., Kenter, G. G., van Beurden, M., van Tinteren, H. and Horenblas, S. (2013), Patients with penile cancer and the risk of (pre)malignant cervical lesions in female partners: a retrospective cohort analysis. BJU International, 112: 905–908. doi: 10.1111/bju.12237
- Issue published online: 11 OCT 2013
- Article first published online: 26 JUL 2013
- Accepted manuscript online: 21 MAY 2013 05:17AM EST
- penile neoplasms;
- human papilloma virus;
- uterine cervical neoplasms
- To determine if female partners of patients with penile cancer have more cervical lesions and neoplasia than would be expected from population-based data.
Patients and Methods
- We included all consecutive patients with primary penile carcinoma in the period 2004–2010.
- Results of Dutch cervical cancer screening were used to consider (pre)malignant cervical lesions in female partners of patients with penile cancer.
- In all, 206 women were included.
- Gynaecological information was available in 195 women: Papanicolaou test (PAP) smears were normal were in 129 partners, 10 smears were abnormal (5.1%, 95% confidence interval 2.5–9.2).
- PAP2 was found in five, PAP3a in two, PAP3b in two women and PAP4 in one woman.
- Colposcopy in two women with PAP3b showed cervical intraepithelial neoplasia grade 3 in both.
- This prevalence was not different from baseline results in the general Dutch population.
- Female partners of patients with penile cancer did not show more premalignant cervical lesions than in the general population.